Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Hanover Insurance
THG
$7.77B
| $15.4M | ﹤0.01% |
83,987
+24,897
| +42% | +$4.48M |
|
1402
CALL
CrowdStrike
CRWD
$230B
| $15.3M | ﹤0.01% |
130,800
+126,800
| +3,170% | +$16.1M |
|
1403
CALL
Equinix
EQIX
$106B
| $15.3M | ﹤0.01% |
+20,000
| New | +$15.7M |
|
1404
CALL
Rubrik
RBRK
$21.6B
| $15.3M | ﹤0.01% |
+200,000
| New | +$15.3M |
|
1405
Pan American Silver
PAAS
$19.9B
| $15.2M | ﹤0.01% |
293,585
-3,980
| -1% | -$167K |
|
1406
CALL
Bloom Energy
BE
$69.6B
| $15.2M | ﹤0.01% |
175,000
| – | – |
|
1407
PUT
BHP
BHP
$222B
| $15.1M | ﹤0.01% |
250,000
| – | – |
|
1408
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $15.1M | ﹤0.01% |
24,976
-130,530
| -84% | -$78.1M |
|
1409
EPR Properties
EPR
$4.73B
| $15.1M | ﹤0.01% |
301,943
+19,107
| +7% | +$995K |
|
|
GES
1410
DELISTED
Guess Inc
GES
| $15.1M | ﹤0.01% |
899,016
+15,856
| +2% | +$268K |
|
1411
CALL
Urban Outfitters
URBN
$6.53B
| $15.1M | ﹤0.01% |
200,000
| – | – |
|
1412
CALL
Maplebear
CART
$11.6B
| $15M | ﹤0.01% |
334,500
-300
| -0.1% | -$12.3K |
|
1413
LCI Industries
LCII
$2.6B
| $15M | ﹤0.01% |
123,260
-16,424
| -12% | -$1.75M |
|
1414
American Healthcare REIT
AHR
$10.3B
| $14.9M | ﹤0.01% |
317,658
+7,261
| +2% | +$337K |
|
1415
Royal Gold
RGLD
$19.1B
| $14.9M | ﹤0.01% |
67,238
-108,281
| -62% | -$21.5M |
|
1416
First Industrial Realty Trust
FR
$8.4B
| $14.9M | ﹤0.01% |
260,702
-44,125
| -14% | -$2.46M |
|
1417
Brinker International
EAT
$10.2B
| $14.9M | ﹤0.01% |
104,012
-148,397
| -59% | -$19.4M |
|
1418
iShares US Transportation ETF
IYT
$2.3B
| $14.9M | ﹤0.01% |
200,063
| – | – |
|
|
SEI
1419
Solaris Energy Infrastructure
SEI
$3.94B
| $14.8M | ﹤0.01% |
322,121
+251,360
| +355% | +$12.2M |
|
1420
Krystal Biotech
KRYS
$9.72B
| $14.8M | ﹤0.01% |
60,062
-15,834
| -21% | -$3.33M |
|
1421
Radian Group
RDN
$4.92B
| $14.8M | ﹤0.01% |
410,810
+159,108
| +63% | +$5.55M |
|
1422
PUT
Verizon
VZ
$200B
| $14.7M | ﹤0.01% |
360,700
| – | – |
|
1423
Corebridge Financial
CRBG
$15.3B
| $14.7M | ﹤0.01% |
486,431
+119,808
| +33% | +$3.68M |
|
1424
Oshkosh
OSK
$9.41B
| $14.6M | ﹤0.01% |
116,423
+4,659
| +4% | +$599K |
|
1425
United States Oil Fund
USO
$1.77B
| $14.6M | ﹤0.01% |
211,453
+156,844
| +287% | +$11.1M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.